Skip to main content
Premium Trial:

Request an Annual Quote

FTC Clears Danaher's Proposed Acquisition of Beckman Coulter

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Federal Trade Commission has granted early termination of the review period for Danaher's proposed $6.8 billion acquisition of Beckman Coulter, according to a notice posted on the agency's website today.

The firms had announced the deal in early February, and at the time said they expected to complete the transaction in the first half of 2011.

Beckman recently reported that its fiscal-year 2010 revenues increased 12 percent to $3.66 billion. Its operations would be added to Danaher's Life Sciences & Diagnostics division, which posted 2010 revenues of $2.3 billion.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.